[Clinical research on malaria: what for the future?]

Area of Science:

• Global Health
• Infectious Diseases
• Clinical Research

Context:

• Malaria persists as a major global public health challenge, with increasing resistance to drugs and insecticides complicating control efforts.
• Despite numerous clinical trials and meta-analyses, the quality of research is often uneven, leading to inconsistent conclusions.
• Heterogeneous epidemiological situations and socioeconomic factors in endemic regions pose significant challenges to implementing interventions.

Purpose:

• To highlight the persistent challenges in malaria clinical research, including trial quality, drug/insecticide resistance, and implementation barriers.
• To underscore the need for enhanced funding and improved research methodologies for developing new antimalarial drugs and interventions.
• To emphasize the importance of ethical considerations and collaborative networks between industrialized and developing countries in malaria research.

Summary:

• Malaria research faces challenges from poor trial quality (10-50% usable) and rising resistance in parasites and vectors.
• Significant funding initiatives aim to boost the development of new antimalarial drugs and large-scale trials.
• Ethical principles must be co-developed with developing nations within collaborative networks to ensure research benefits affected populations.

Impact:

• Enhanced funding and improved research design are expected to accelerate the discovery of new antimalarial drugs.
• Strengthening collaborative networks and ethical frameworks will improve the relevance and effectiveness of malaria interventions.
• Addressing trial quality and implementation barriers is essential for ultimately reducing the global burden of malaria.